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Abstract
Background: 2-D Echo is often performed in patients without history of coronary artery disease
(CAD). We sought to determine echo features predictive of CAD.
Methods: 2-D Echo of 328 patients without known CAD performed within one year prior to
stress myocardial SPECT and angiography were reviewed. Echo features examined were left
ventricular and atrial enlargement, LV hypertrophy, wall motion abnormality (WMA), LV ejection
fraction (EF) < 50%, mitral annular calcification (MAC) and aortic sclerosis/stenosis (AS). High risk
myocardial perfusion abnormality (MPA) was defined as >15% LV perfusion defect or multivessel
distribution. Severe coronary artery stenosis (CAS) was defined as left main, 3 VD or 2VD involving
proximal LAD.
Results: The mean age was 62 ± 13 years, 59% men, 29% diabetic (DM) and 148 (45%) had > 2
risk factors. Pharmacologic stress was performed in 109 patients (33%). MPA was present in 200
pts (60%) of which, 137 were high risk. CAS was present in 166 pts (51%), 75 were severe. Of 87
patients with WMA, 83% had MPA and 78% had CAS. Multivariate analysis identified age >65, male,
inability to exercise, DM, WMA, MAC and AS as independent predictors of MPA and CAS.
Independent predictors of high risk MPA and severe CAS were age, DM, inability to exercise and
WMA.
2-D echo findings offered incremental value over clinical information in predicting CAD by
angiography. (Chi square: 360 vs. 320 p = 0.02).
Conclusion: 2-D Echo was valuable in predicting presence of physiological and anatomical CAD
in addition to clinical information.
Background
Two-Dimensional echocardiography (2-D Echo) is well
accepted for evaluation of cardiac function. [1] It is the
most employed cardiovascular imaging modality for
assessment of cardiovascular disease and is often per-
formed in patients without history of coronary artery dis-
ease (CAD). It is well established that several
echocardiograpahic measurements provide powerful
prognostic information for cardiovascular outcomes such
as presence of left ventricular hypertrophy, aortic sclerosis
and LVEF. [1,2] However, the association of these features
with underlying CAD is less well established. [3-5]
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Although association of CAD and some isolated echo
findings have been examined, no study have performed a
direct comparison of different echo feature in predicting
CAD in patients without history of CAD. Therefore, we
sought to compare different echo findings to determine
independent 2-D echo predictors of underlying anatomi-
cal CAD by angiographic coronary artery stenosis (CAS)
and also physiological CAD by myocardial perfusion
abnormality (MPA) by SPECT. Stress myocardial SEPCT
imaging is the most commonly used imaging technique in
assessment of suspected CAD. It provides high diagnostic
accuracy for detection of angiographic CAD and adds
incremental prognostic value over angiographic informa-
tion. [6-8]
Methods
Study Population
We conducted a search of the cardiac imaging database of
a large tertiary hospital to identify retrospectively 328
patients who had no known CAD, prior myocardial inf-
arction or revascularization and underwent two -dimen-
sional echo (TTE), stress myocardial perfusion with
SPECT and coronary angiography. The tests (echo and
SPECT) were ordered as per discretion of the treating phy-
sicians. The most common indications for SPECT were
assessment of chest pain or CAD or preoperative evalua-
tion.
The echocardiograms were performed within one year
prior to stress myocardial SPECT. The indication for TTE
was for assessment of left ventricular or valvular function.
All patients underwent angiography within 3 months of
SPECT. Patients were referred for coronary angiography
by their treating physician based on the clinical presenta-
tion or SPECT findings.
Clinical characteristics and 12 leads ECG were prospec-
tively collected at the time of SPECT. The clinical risk fac-
tors for CAD assessed were diabetes, hypertension, and
hyperlipidemia, family history of CAD and history of
smoking.
Abnormal ECG were defined as presence of any patholog-
ical Q waves, ST and T waves abnormalities, left ventricu-
lar hypertrophy, rhythm other than normal sinus rhythm
and presence of AV nodal or bundle branch conduction
abnormality.
TTE Data
The TTE studies were performed with commercially avail-
able system (Acuson Sequoia C 256 or HP SONOS 5500).
The studies were interpretated prior to SPECT by three
expert level 3 echocardiographers who are board certified
by the National Board of Echocardiography. Patient with
prosthetic valves or severe valvular disease were excluded
from this study. Two dimensional echocardiographic
assessments were made using standard ASE recommenda-
tion. [9] The definition of echo abnormality is as fol-
lowed:
-left ventricular enlargement (LVE): maximal LV end
diastolic diameter > 50 mm at parasternal long axis view
-LV hypertrophy (LVH): LV septum and posterior wall >
1.2 cm by 2D measurement in parasternal long axis view
in the absence of small left ventricular size
-presence of any wall motion abnormality (WMA) assess-
ment as per ASE recommendation [9]
-LV ejection fraction (LVEF) > = 50% or < 50% by qualita-
tive analysis or multiple diameter method [10]
-left atrial enlargement (LAE): 2 dimensional maximal
volume of > 50 ml for male and > 45 ml for female by
multidisks method at apical four chambers view [11]
-mitral annular calcification (MAC) as focal or diffuse
echogenic structure located at the junction of the atrioven-
tricular groove and posterior mitral valve leaflet on par-
asternal long, short axis or apical four chambers view
-aortic sclerosis (AS): focal area of increased echogenicity,
thickening, or calcification of the aortic valve leaflets with
peak aortic valve CW Doppler velocity < 2 m/sec for aortic
sclerosis and > = 2 m/sec for aortic stenosis
Gated Stress Myocardial Perfusion Imaging
Symptoms limited treadmill exercise using the Bruce pro-
tocol or four minutes adenosine stress imaging were per-
formed as previously described. [12,13]All SPECT images
interpretation and quantification was performed by two
expert level 3 nuclear cardiologists. TTE results were not
available for SPECT interpretation. The rest and stress
polar maps were independently computer-generated and
normalized through use of a circumferential profile anal-
ysis. The presence and extent of defect were quantified as
previously described. [14] High risk MPA by SPECT was
defined as >15% LV perfusion defect, LAD or multivessel
distribution.
Coronary Angiography
Qualitative visual analysis was used for coronary angiog-
raphy evaluation. Coronary artery stenosis (CAS) was
defined as presence of > 50% luminal diameter stenosis in
one of the three major epicardial vessel or its major
branches.
Severe CAS was defined as left main stenosis > 50%, 3 VD
or 2VD involving proximal left anterior descending coro-
nary artery.Cardiovascular Ultrasound 2009, 7:10 http://www.cardiovascularultrasound.com/content/7/1/10
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Statistical Analysis
Data are presented as mean ± SD. Chi-square or Fisher
exact test was used for categorical variables comparison.
All echo findings were presented as categorical variables.
The two-sample unpaired Student's t-test was used to
compare the continuous variables. Univariate analysis
was used by comparing the presence of CAD with echo
findings. Multivariable analysis using logistic regression
was applied for the prediction of coronary artery disease.
All collected variables were entered in the model at the
same time. A p-value <0.05 was considered significant.
Sigma Stat 3.1 was used for all analyses.
Results
Baseline Characteristics
Baseline clinical and echocardiographic characteristics are
shown in Table 1.
The group's mean age was 62 ± 14 years, 59% were men
and 29% had history of diabetes mellitus. Forty-five per-
cent of patients had 2 or more clinical risk factors.
Abnormal baseline ECG was present in 245 patients
(74%) and in 55% of patients angina was the indication
for SPECT. Pharmacologic stress in conjunction with
SPECT imaging was performed in 109 pts (33%) due to
inability to exercise. In the remaining subjects, treadmill
stress testing was utilized with SPECT.
Myocardial SPECT and angiographic data are shown in
Table 2. MPA was present in 201 patients (60%) of which,
137 were high risk. CAS by angiography was present in
165 patients (51%). Severe disease was present in 75
patients.
2-D echo predictors of CAD (Table 3)
2 D echo finding associated with presence of MPA and
CAS based on univariables analysis is shown in table 2.
LVE, LVH, EF < 50%, WMA, MAC and AS were predictors
of perfusion defects by SPECT. On the other hand, LVEF <
50%, WMA, MAC and AS were predictors of CAS by angi-
ography. Of those 87 patients who had WMA on resting
echocardiography, 83% had MPA by SPECT and 78% had
CAS by angiography. Sixty-nine patients had an EF < 50%.
Of these, 84% had MPA by SPECT and 65% had CAS by
angiography.
Independent predictors of CAD
Multiple logistic regression analysis were performed for
the entire cohort of patients. Age >65 yrs, male gender,
inability to exercise, diabetes, WMA, MAC and AS were
independent predictors of perfusion defects by SPECT and
CAS by angiography (Table 4). Independent predictors of
high risk MPA by SPECT and severe CAS by angiography
were age, diabetes, inability to exercise and presence of
WMA. (Table 5)
All but one of 15 diabetic patients with age > 65 yrs, una-
ble to exercise, with EF <50% and WMA had CAD by ang-
iography.
Incremental value of 2D echocardiographic findings 
(Figure 1)
2D echocardiographic findings had an incremental value
over clinical information in predicting CAD by SPECT and
angiography. (Chi square: 360 vs. 320 p = 0.02).
Discussion
More than half of patients with major Q/QS wave's
changes from the Cardiovascular Health Study did not
report a previous myocardial infarction. [15] Echocardi-
ography is often performed and abnormality found in
patients without known CAD. Therefore it might offer a
unique opportunity to identify patients with unsuspected
CAD who might have a worse outcome and warrant early
medical or invasive intervention. [2]
Previous studies have shown that some isolated echo fea-
tures are associated with underlying CAD either using
marker of CAD like SPECT, stress Echo or angiography.
[16-18] However, very few of them performed a direct
comparison of different echo features in predicting CAD
in patients without history of CAD. To the best of our
knowledge, current study is the first to correlate multiple
Table 1: Baseline Clinical and 2-D Echo Characteristics
Mean Age (years) 62 ± 14
Age > 65 years 156 (48%)
Male gender 193 (59%)
Chest Pain as indication for SPECT 180 (55%)
DM 95 (29%)
Hypertesion 178 (55%)
Hyperlipidemia 77 (24%)
History of smoking 98 (30%)
Family history of CAD 98 (30%)
Number of Risk Factors 1.7 ± 1
Abnormal Rest ECG 245 (74%)
Unable to Exercise 109 (33%)
2-D Echo Features
LVE 71 (22%)
LVH 170 (52%)
LVEF < 50% 69 (21%)
WMA 87 (27%)
LAE 174 (53%)
MAC 142 (43%)
AS 155 (47%)
DM: Diabetes Mellitus
LVE: left ventricular enlargement
LAE: left atrial enlargement
LVH: LV hypertrophy
WMA: wall motion abnormality
LVEF: LV ejection fraction
MAC: mitral annular calcification
AS: aortic sclerosis/stenosisCardiovascular Ultrasound 2009, 7:10 http://www.cardiovascularultrasound.com/content/7/1/10
Page 4 of 8
(page number not for citation purposes)
Table 2: Myocardial SPECT and Angiographic Data
SPECT
Normal MPI 127 39%
Abnormal MPI 201 61%
High Risk Scan 137 42%
Predominant ischemic Defect 156 48%
Predominant Fixed Defect 45 13%
Perfusion Defect Size (% Left Ventricle) 19 ± 12
ANGIOGRAPHY
No significant CAS 163 49%
One vessel Disease 55 17%
Two vessels Disease without involving proximal LAD 35 11%
Two vessels Disease involving proximal LAD 19 6%
Three vessels or left main Disease 56 17%
MPI: myocardial perfusion imaging, CAS: coronary artery stenosis, LAD: left anterior descending artery
Table 3: Correlation of 2 D Echo Features with MPI and CAS
Abnormal MPI P = CAS P =
LVE yes 53/71 75% 0.013 39/71 55% 0.49
no 148/257 57% 126/257 49%
LVH yes 90/170 53% 0.002 79/170 47% 0.18
no 111/158 70% 86/158 54%
LVEF <50% 58/69 84% <0.001 45/69 65% 0.01
> = 50% 143/259 55% 120/259 46%
WMA yes 73/87 83% <0.001 56/87 65% 0.004
no 138/241 53% 109/241 45%
LAE yes 101/174 58% 0.24 74/174 42% 0.17
no 100/154 64% 78/154 50%
MAC yes 110/142 77% <0.001 87/142 62% <0.001
no 108/186 58% 77/186 42%
AS yes 105/155 68% 0.003 99/155 64% <0.001
no 96/173 55% 66/173 38%
LVE: left ventricular enlargement
LAE: left atrial enlargement
LVH: LV hypertrophy
WMA: wall motion abnormality
LVEF: LV ejection fraction
MAC: mitral annular calcification
AS: aortic sclerosis/stenosisCardiovascular Ultrasound 2009, 7:10 http://www.cardiovascularultrasound.com/content/7/1/10
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2 D echo findings to both physiological (myocardial per-
fusion SPECT imaging) and anatomical CAD (angiogra-
phy). We showed that 2D echo information has indeed
significant discriminative power in identifying underlying
newly diagnosed CAD in addition to known clinical risk
factors.
Calcium deposit
Compared to the newer technology for detection of cal-
cium such as cardiac CT, echocardiography is cheaper and
there are no concerns for risk associated with ionizing
radiation. Cardiovascular calcium deposits such as mitral
annulus calcification and aortic sclerosis are thought to be
a marker of generalized degenerative vascular process.
They have been associated with a higher prevalence and
incidence of coronary risk factors as well as CAD [19-21].
In one study, multiple calcium deposit (mitral annulus,
aortic valve and aorta) have been associated with presence
of abnormal myocardial perfusion imaging in patients
younger than 65 years. However, patients with known
CAD were not excluded, other echo findings were not
examined and no angiographic data were reported. [18]
In our study both mitral annulus calcification and aortic
sclerosis were indeed associated with higher prevalence of
myocardial perfusion abnormality and angiographic
CAD. However their presence was not associated inde-
pendently with more severe CAD when other echo abnor-
mality such as WMA was present.
Wall motion abnormality
The presence of resting WMA might represent underlying
myocardial damage due to infarction, hibernation or
stunning secondary to atherosclerotic CAD or non-
ischemic insult to myocardium. [22-24] Therefore,
although a resting WMA is associated with a higher cardi-
ovascular event rate [25,26]; controversy still exists regard-
ing the value of WMA in predicting CAD. [24] One recent
study reported that resting WMA was predictive of abnor-
Table 4: Multivariate Logistic regression Analysis: Independent predictors of MPA by SPECT and CAS by angiography
Odds Ratio 95% Confidence Intervals P- value
CAS age> 65 2.9 1.7–4.9 0.002
Male 2.2 1.3–3.7 0.02
Inability to exercise 2.9 1.5–5.5 <0.001
DM 4.1 2.2–7.9 <0.001
WMA 3 1.3–7.1 0.007
MAC 2.2 1.2–3.7 0.03
AS 2.3 1.3–3.9 0.03
MPA age> 65 1.4 1–2.5 0.05
Male 2.7 1.7–4.8 <0.001
Inability to exercise 3.1 1.8–5.3 <0.001
DM 2.1 1.1–4 0.02
WMA 2.2 1.1–6 0.04
MAC 2 1.1–3.5 0.03
DM: Diabetes Mellitus
WMA: wall motion abnormality
MAC: mitral annular calcification
AS: aortic sclerosis/stenosis
Table 5: Multivariate Logistic regression Analysis: Independent predictors of High risk MPA by SPECT and severe CAS by 
angiography
Odds Ratio 95% Confidence Intervals P
Severe CAS age> 65 3.76 1.97–7.17 <0.001
Inability to exercise 2.9 1.01–5.5 0.04
DM 4.5 2.2–5.7 0.001
WMA 2.4 1.02–5.7 0.04
High Risk MPA age> 65 2.2 1.3–3.7 0.003
Inability to exercise 1.7 1.0–2.8 0.05
DM 2.8 1.5–5.0 0.001
WMA 2.26 1.05–4.9 0.02
MAC 1.9 1.08–3.3 0.01
DM: Diabetes Mellitus
WMA: wall motion abnormality
MAC: mitral annular calcificationCardiovascular Ultrasound 2009, 7:10 http://www.cardiovascularultrasound.com/content/7/1/10
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mal myocardial perfusion by SPECT and ischemic
response on dobutamine stress echo in 116 patients with-
out known CAD or MI. [17]
Our results show that the resting WMA is indeed predic-
tive of abnormal myocardial perfusion and obstructive
coronary disease. Approximately 80% of these patients
with WMA had CAD by SPECT or angiography. Moreover
it is the only independent 2-D Echo predictor of high risk
CAD. Indeed, in our study elderly diabetic patients unable
to exercise with low EF and WMA appeared to be of high-
est risk of severe CAD.
Several of our patients (n = 11) have only fixed defect on
SPECT but have no WMA on echo. This could be either
due to attenuation artifact on SPECT or silent MI during
time interval between performance of echo and MPI or
angiography. In addition, it has also been reported that up
to 30% of regions with fixed perfusion defect could have
evidence of viability on echocardiography which has nor-
mal resting wall motion or resting hypokinesis worsened
during exercise. [27]
Left ventricular ejection fraction
Left ventricular ejection fraction is a well known prognos-
tic marker for cardiovascular event. [3] But most of the
adverse event is related to. In current study, it is associated
with myocardial perfusion abnormality and angiographic
CAD. However the association was no longer significant
after adjustment for other clinical and echocardiographic
factors such as wall motion abnormality. Several prior
studies appeared to indirectly support our finding. In
multivariable models, resting wall motion score index
appears to be a more powerful predictor of combined car-
diovascular event than LVEF in both post MI patients and
patients evaluated for coronary artery disease [28,29]
Left ventricular hypertrophy
Eccentric or concentric hypertrophy has been found to
confer increased risk of incident coronary heart disease in
The Framingham Heart Study and The Cardiovascular
Health Study using M- mode echocardiography. [5,30] In
our study the LV enlargement and hypertrophy were asso-
ciated with perfusion abnormality but not with angio-
graphic CAD. The discrepancy could be explained by
different echo technique used and population studied.
Also it is well known that non ischemic cardiomyopathy
or hypertrophic cardiomyopathy could cause myocardial
perfusion changes due to abnormal myocardial flow
reserve in the absence of epicardial artery obstruction.
[31,32]
Left atrial enlargement
Left atrial enlargement have been shown to be a predictor
of CV event in the The Cardiovascular Health Study. [30]
However, except for higher risk of CHF, the association
with other CV events is no longer present after adjustment
of clinical risk factors. Theoretically left atrial enlargement
could occur with increased filling pressure as a result of
silent LV dysfunction secondary to CAD. However, it was
not a predictor of CAD in our study. The explanation
could be that LAE is more a direct indicator of underlying
myocardial diastolic abnormality [33] rather than under-
lying atherosclerotic disease.
Relation between echocardiography, myocardial perfusion 
imaging and angiography
Although the predictors of echo findings for either MPA or
CAS were very similar, the predictive power was different.
MPA correlates well with invasive angiographic findings
but both false positive and negatives do occur. False posi-
tive tests could be due to attenuation artifacts, reduction
of coronary flow reserve as in diabetics, hypertensives or
Incremental value of 2D Echo Data over Clinical Information in Predicting CAD Figure 1
Incremental value of 2D Echo Data over Clinical Information in Predicting CAD. a: Coronary artery stenosis by 
CATH. b: Myocardial perfusion abnormality by SPECT.
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hypertrophy with micro vascular disease in the absence of
significant epicardial stenosis or non ischemic cardiomy-
opathy. [34,35] False negatives may be due to underesti-
mation of flow heterogeneity or balanced ischemia. [36]
However, it is well known that not all coronary stenosis
are hemodynamically significant and may not induce per-
fusion abnormalities.
Several echo features provide powerful prognostic infor-
mation in terms of cardiovascular outcomes such as
death, CHF, infraction and stroke. However it is unclear if
such abnormalities on echo are mere markers of other
underlying disease or have direct pathogenic implication.
By using intermediate cardiac endpoints such as presence
of CAD, our findings provide some insight into the poten-
tial pathophysiologic mechanism of the association
between echo finding and cardiovascular outcomes. Our
findings appear to suggest that the adverse prognosis of
wall motion abnormality and calcium deposits are proba-
bly more directly related to CAD whereas the chambers
enlargement are probably more directly related to under-
lying myocardial systolic or diastolic dysfunction.
Limitations
Our study has several limitations.
The retrospective nature of our analysis carried associated
referral or selection bias. Patient was referred for TTE for
assessment of LV and valve function and could have been
referred for MPI when abnormal TTE finding was availa-
ble to ordering physicians.
There was also a time interval between echo, MPI or angi-
ography. We cannot exclude silent cardiovascular event or
rapid progression of CAD during the time interval
between TTE and MPI. Such progression could affect neg-
atively the predictive power of echo findings. Our defini-
tion of LVH was based on increased wall thickness rather
than LV mass calculation. However, in the CHS, increased
LV wall thickness confers similar prognostic information
as LV mass. [29] Detailed ECG analysis was not performed
which could affect the predictive power of the echo find-
ing. We performed our analysis using only binary varia-
bles and did not examine the potential correlation of
different degree of LVEF, wall motion score and calcifica-
tion with the severity of CAD. On the other hand, this
simplified approach would be easier to apply in the clini-
cal setting. Finally, outcome data were not available to
explore the link between presence of CAD and adverse
cardiovascular outcome associated with certain TTE
abnormality.
Clinical implications
Despite the predictive value of echo, we do not advocate
use of TTE as screening test for unsuspected CAD. But
when 2-D Echo is performed in patients without known
CAD, we believe that certain scenario should prompt the
clinicians to consider presence of significant underlying
CAD and further diagnostic testing (such stress testing)
might be warranted. 1) presence of depressed EF and
WMA 2) presence of multiple calcification, in certain
patient population (such as elderly, diabetic patients and
unable to exercise)
Conclusion
Several features in resting 2-D Echo provide incremental
value over clinical information in predicting presence of
physiological and anatomical CAD in patients without
known CAD.
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